{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:51:08Z","timestamp":1780581068569,"version":"3.54.1"},"reference-count":78,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"not been funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2019,7,24]]},"DOI":"10.1080\/14656566.2019.1617849","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T12:43:21Z","timestamp":1558961001000},"page":"1321-1330","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Asenapine for the treatment of bipolar disorder"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-5829","authenticated-orcid":false,"given":"Donatella","family":"Marazziti","sequence":"first","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-8237","authenticated-orcid":false,"given":"Federico","family":"Mucci","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Falaschi","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Dell\u2019Osso","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00241-X"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596.dsm03"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622970902823202"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12025"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000018"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116636545"},{"key":"e_1_3_5_10_1","volume-title":"Sycrest: EPAR\u2014product information","author":"European Medicines Agency","year":"2015","unstructured":"European Medicines Agency. Sycrest: EPAR\u2014product information. London: European Medicines Agency; 2015."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0197-8"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160525115014"},{"key":"e_1_3_5_13_1","first-page":"59","volume-title":"Clinical psychopharmacotherapy","author":"Tundo A.","year":"2018","unstructured":"Tundo A. Manic and hypomanic episodes. In: Marazziti D, editor. Clinical psychopharmacotherapy. Rome: Giovanni Fioriti Editore; 2018. p. 59\u201370."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00749.x"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1102"},{"issue":"7","key":"e_1_3_5_16_1","first-page":"4","article-title":"Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia","volume":"65","author":"Casey DE","year":"2004","unstructured":"Casey DE, Haupt DW, Newcomer JW, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry. 2004;65(Suppl 7):4\u201318. quiz 19\u201320. PMID: 15151456","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000142281.85207.d5"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000278"},{"key":"e_1_3_5_19_1","unstructured":"AdisInsight Drugs. Asenapine. AdisInsight. 2017. [cited 2018 Mar 31]. Available from: http:\/\/adisinsight.springer.com\/drugs\/800001124"},{"key":"e_1_3_5_20_1","unstructured":"Food and Drug Administration. Approval letter. Rockville MD. Food and drug administration. 2009. [cited 2018 Mar 31]. Available from: https:\/\/www. access data.fda.gov\/drugsatfda_docs\/nda\/2009\/022117s000_Approv.pdf"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00911-5"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107082944"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.11.001"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12272"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705005328"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.5.1552"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852917000165"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.07.002"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.11.015"},{"key":"e_1_3_5_31_1","unstructured":"FDA Psychopharmacology Drugs Advisory Committee Meeting. S.A.S.T. 30 July 2009. NDA 22\u2013117. Food and drug administration. 2009. [cited 2018 Mar 31]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022117s000_MedR_P1.pdf"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9839-7"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.908185"},{"issue":"5","key":"e_1_3_5_34_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.718","article-title":"Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects","volume":"31","author":"Gerrits M","year":"2010","unstructured":"Gerrits M, de Greef R, Peeters P. Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects. Biopharm Drug Dispos. 2010;31(5\u20136):351\u2013357. PMID: 20549835","journal-title":"Biopharm Drug Dispos"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.765859"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/11200860-000000000-00000"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/11590490-000000000-00000"},{"key":"e_1_3_5_38_1","unstructured":"Allergan. SAPHRIS (asenapine) 2.5 mg sublingual tablets for the acute treatment of manic or mixed episodes of bipolar I disorder in pediatric patients (ages 10\u201317). [cited 2018 Mar 31]. Available from: https:\/\/www.allergan.com\/news\/news\/thomson-reuters\/actavis-receives FDA-approval-of-saphris-for-pedia"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00748.x"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.12.028"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.06.059"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.04.005"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117705098"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.07.013"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.025"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.01.024"},{"key":"e_1_3_5_47_1","volume-title":"Manic-depressive illness: bipolar bisorders and recurrent depression","author":"Goodwin FK","year":"2007","unstructured":"Goodwin FK, Jamison KR. Manic-depressive illness: bipolar bisorders and recurrent depression. 2nd ed. New York: Oxford University Press; 2007.","edition":"2"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-014-0139-3"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.914030"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-11-101"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08827"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.874988"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31823f872f"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.526"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.938047"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.01.003"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(15)30353-9"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-16"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16040419"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.09.037"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4213"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2012.05.027"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2016.01.012"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2015.09.007"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-016-0184-2"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S165743"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S149376"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000206"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316674698"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S41333"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.908183"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.943732"},{"key":"e_1_3_5_74_1","doi-asserted-by":"crossref","unstructured":"Butler M Urosevic S Desai P et al. Treatment for bipolar disorder in adults: a systematic review. AHRQ comparative effectiveness reviews. Rockville (MD); 2018. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532183\/","DOI":"10.23970\/AHRQEPCCER208"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1162\/152651602317533523"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0592-2"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359786813482534"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/pnp.307"},{"key":"e_1_3_5_79_1","first-page":"503601","article-title":"Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine","volume":"2013","author":"Buoli M","year":"2013","unstructured":"Buoli M, Dobrea C, Caldiroli A, et al. Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine. Case Rep Psychiatry. 2013;2013:503601. PMID: 24171130","journal-title":"Case Rep Psychiatry"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.02.014"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2019.1617849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:28:37Z","timestamp":1770398917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2019.1617849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,7,24]]}},"alternative-id":["10.1080\/14656566.2019.1617849"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2019.1617849","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}